"10.1371_journal.pone.0076110","plos one","2013-10-03T00:00:00Z","David K Walmer; Paul S Eder; Laura Bell; Hiam Salim; Lori Kobayashi; Jackie Ndirangu; Nicole Tinfo; Philip E Castle","Family Health Ministries, Durham, North Carolina, United States of America; Duke Global Health Institute, Durham, North Carolina, United States of America; Qiagen Sciences, Inc., Gaithersburg, Maryland, United States of America; Global Cancer Initiative, Chestertown, Maryland, United States of America","Conceived and designed the experiments: DKW PSE LB HS LK JN NT. Performed the experiments: JN PSE LB HS LK. Analyzed the data: DKW PSE JN NT PEC. Contributed reagents/materials/analysis tools: DKW PSE LB HS LK JN NT. Wrote the manuscript: DKW PSE LB JN NT PEC.","Dr. Castle has served as a consultant to BD, Roche, Cepheid, and GE Healthcare. Dr. Castle has been compensated as member of a data and safety monitoring board for HPV Vaccines for Merck. Dr. Castle has received HPV tests and
reagents for research at a reduced or no cost from Qiagen, Roche, Norchip, and mtm. Dr. Eder currently owns equity in Qiagen. Ms. Bell and Ms. Salim are currently employees of Qiagen. Ms. Salim currently owns equity in Qiagen. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","10","David K Walmer","DKW",8,TRUE,7,5,5,6,TRUE,TRUE,FALSE,0,NA,FALSE
